Drug Trial Radar · NCT05543681
Clinical Trial on Agitation in Alzheimer's Dementia
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
164
Planned (sponsor's estimate)
Start
Oct 11, 2022
Primary completion
Nov 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- IGC Pharma, LLCIndustry
- Sponsor type
- Industry
- First posted
- Sep 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a day on Agitation in patients with mild to severe dementia from Alzheimer's.
Conditions
- Alzheimer Disease
- Agitation,Psychomotor
- Care Giving Burden
- NPS
- Aggression
Interventions
IGC-AD1-ActiveDrug
A non-sterile solution for oral administration.
IGC-AD1-PlaceboDrug
A non-sterile solution for oral administration similar in color and texture to the Active.
Primary outcomes
What the sponsor says the trial is designed to measure.
- AgitationTime frame: Baseline to week six
Locations
28 sites in 3 countries. Site status is shown where the registry gives one.
ClinCloud, LLC
Maitland, Florida
ClinCloud, LLC
Melbourne, Florida
Central Miami Medical Institute
Miami, Florida
Visionary Investigators Network
Miami, Florida
Miami Jewish Health
Miami, Florida
Neurostudies Inc.
Port Charlotte, Florida
University of South Florida Department of Psychiatry and Behavioral Neurosciences
Tampa, Florida
Tandem Clinical Research GI, LLC
Metairie, Louisiana
MedStar Franklin Square Medical Center Neurology
Baltimore, Maryland
Medstar Southern Maryland Hospital Center
Clinton, Maryland
Medstar Montgomery Medical Center
Olney, Maryland
Tekton Research LLC
St Louis, Missouri
Dent Neurologic Institute
Amherst, New York
Integrative Clinical Trials, LLC
Brooklyn, New York
Ichor Research
Syracuse, New York
Lynn Health Science Institute (LHSI)
Oklahoma City, Oklahoma
Butler Hospital, Brown University
Providence, Rhode Island
Senior Adults Specialty Research
Austin, Texas
Baylor Scott and White Research Institute
Dallas, Texas
Kerwin Medical Center
Dallas, Texas
Dominion Medical Associates, Inc.
Richmond, Virginia
Island Health Authorities
Victoria, British Columbia, Canada
Hamilton Health Sciences , Mcmaster University
Hamilton, Ontario, Canada
Baycrest Academy for Research and Education , University of Toronto
Toronto, Ontario, Canada
Douglas Hospital Research Center, McGill university
Montreal, Quebec, Canada
SCB Research Center Corp
Bayamón, Puerto Rico
The Alliance, Medical Sciences Campus University of Puerto Rico
Rio Piedras, Puerto Rico
Instituto Sanacoop
Bayamón, Bayamón, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.